Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
On 25 September 2025, the EPO’s Enlarged Board of Appeal (‘EBoA’) issued its decision in case G 2/24, the third…
Read More
In the context of intellectual property (IP), a hidden and potentially costly issue with using AI tools is confidentiality. This…
Read More
Over the past few years, the issue of whether the description of a European patent or application should be amended…
Read More
The EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
Read More
Following the SkyKick v. Sky decision – which we covered in an earlier article – the key takeaway was that…
Read More
The EPO’s Enlarged Board of Appeal (EBA) has now issued their decision on G1/24 the referral relating to claim interpretation…
Read More
This article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
Read More
Intention to use it or lose it? Trainee trade mark attorney Joe Gargano explains that while Sky and SkyKick settled…
Read More
The Enlarged Board of Appeal has issued its preliminary opinion ahead of the upcoming oral proceedings on the G1/24 referral…
Read More
Emotional Perception AI Ltd (EPAIL) have been granted leave to appeal by the UK Supreme Court. This follows a series…
Read More
Complications following a recent Board of Appeal decision Certain categories are considered by the European Patent Convention to be either…
Read More